Behandling med Thelin førte til en nettoforbedring i WHO- funktionsklasse hos 12% af patienterne (placebo - 3%, p < 0, 05).
Treatment with Thelin led to net improvement in WHO functional class in 12% of patients (placebo -3%, p < 0.05).